ProfileGDS4459 / ENSG00000198933
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 13% 36% 41% 50% 38% 43% 35% 35% 42% 46% 40% 39% 43% 35% 35% 64% 48% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.0213
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 23.9536
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 33.9941
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.5250
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.9338
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.1543
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 73.835
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 83.7735
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 94.0542
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.2646
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.9640
GSM623475group B, liver allograft wedge biopsie placebo treatment 23.8839
GSM623476group B, liver allograft wedge biopsie placebo treatment 34.1643
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9535
GSM623478group B, liver allograft wedge biopsie placebo treatment 53.7435
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.8964
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.348